Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Dissolution mechanisms of felodipine solid dispersions.

Park K.

J Control Release. 2014 Aug 28;188:101. doi: 10.1016/j.jconrel.2014.07.036. No abstract available.

PMID:
25079035
2.

Real time Raman imaging to understand dissolution performance of amorphous solid dispersions.

Tres F, Treacher K, Booth J, Hughes LP, Wren SA, Aylott JW, Burley JC.

J Control Release. 2014 Aug 28;188:53-60. doi: 10.1016/j.jconrel.2014.05.061. Epub 2014 Jun 5.

3.

[Study on the properties of felodipine solid dispersions prepared by different technologies].

Shi NQ, Zhang H, Zhang Y, Feng B, Li ZQ, Qi XR.

Beijing Da Xue Xue Bao. 2016 Dec 18;48(6):1067-1073. Chinese.

4.

Mechanistic insights into the dissolution of spray-dried amorphous solid dispersions.

Langham ZA, Booth J, Hughes LP, Reynolds GK, Wren SA.

J Pharm Sci. 2012 Aug;101(8):2798-810. doi: 10.1002/jps.23192. Epub 2012 May 16.

PMID:
22592919
5.

Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.

Konno H, Handa T, Alonzo DE, Taylor LS.

Eur J Pharm Biopharm. 2008 Oct;70(2):493-9. doi: 10.1016/j.ejpb.2008.05.023. Epub 2008 Jun 6.

PMID:
18577451
6.

[Analysis and evaluation of the impurity of felodipine and its tablets].

Zhang N, Yu LJ, Li J, Tong JW, Meng J, Zhang QM, Shi YQ.

Yao Xue Xue Bao. 2012 Feb;47(2):223-8. Chinese.

PMID:
22512035
7.

A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.

Mahmah O, Tabbakh R, Kelly A, Paradkar A.

J Pharm Pharmacol. 2014 Feb;66(2):275-84. doi: 10.1111/jphp.12099. Epub 2013 Jul 10.

PMID:
24433426
8.

Evaluation of controlled-release polar lipid microparticles.

Savolainen M, Khoo C, Glad H, Dahlqvist C, Juppo AM.

Int J Pharm. 2002 Sep 5;244(1-2):151-61.

PMID:
12204574
9.

Preparation of a solid dispersion of felodipine using a solvent wetting method.

Kim EJ, Chun MK, Jang JS, Lee IH, Lee KR, Choi HK.

Eur J Pharm Biopharm. 2006 Oct;64(2):200-5. Epub 2006 Apr 27.

PMID:
16750355
10.

Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications.

Qian F, Wang J, Hartley R, Tao J, Haddadin R, Mathias N, Hussain M.

Pharm Res. 2012 Oct;29(10):2765-76.

PMID:
22315020
11.

Effect of poloxamer on the dissolution of felodipine and preparation of controlled release matrix tablets containing felodipine.

Lee KR, Kim EJ, Seo SW, Choi HK.

Arch Pharm Res. 2008 Aug;31(8):1023-8. doi: 10.1007/s12272-001-1263-9. Epub 2008 Sep 12.

PMID:
18787792
12.

Dissolution and precipitation behavior of amorphous solid dispersions.

Alonzo DE, Gao Y, Zhou D, Mo H, Zhang GG, Taylor LS.

J Pharm Sci. 2011 Aug;100(8):3316-31. doi: 10.1002/jps.22579. Epub 2011 May 23.

PMID:
21607951
13.

Alternative solvent-free preparation methods for felodipine surface solid dispersions.

Kerc J, Srcic S, Kofler B.

Drug Dev Ind Pharm. 1998 Apr;24(4):359-63.

PMID:
9876596
14.
15.

Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.

Tian Y, Caron V, Jones DS, Healy AM, Andrews GP.

J Pharm Pharmacol. 2014 Feb;66(2):256-74. doi: 10.1111/jphp.12141. Epub 2013 Nov 5.

PMID:
24192445
16.

Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions.

Rumondor AC, Stanford LA, Taylor LS.

Pharm Res. 2009 Dec;26(12):2599-606. doi: 10.1007/s11095-009-9974-3. Epub 2009 Oct 6.

PMID:
19806435
17.

Multicomponent solid forms of felodipine: preparation, characterisation, physicochemical and in-vivo studies.

Chadha R, Sharma M, Haneef J.

J Pharm Pharmacol. 2017 Mar;69(3):254-264. doi: 10.1111/jphp.12685. Epub 2017 Jan 30.

PMID:
28134976
18.

Understanding the behavior of amorphous pharmaceutical systems during dissolution.

Alonzo DE, Zhang GG, Zhou D, Gao Y, Taylor LS.

Pharm Res. 2010 Apr;27(4):608-18. doi: 10.1007/s11095-009-0021-1. Epub 2010 Feb 12.

PMID:
20151181
19.

Nimodipine (NM) tablets with high dissolution containing NM solid dispersions prepared by hot-melt extrusion.

Jijun F, Lishuang X, Xiaoli W, Shu Z, Xiaoguang T, Xingna Z, Haibing H, Xing T.

Drug Dev Ind Pharm. 2011 Aug;37(8):934-44. doi: 10.3109/03639045.2010.550301. Epub 2011 Mar 21.

PMID:
21417606
20.

Evaluation of polar lipid-hydrophilic polymer microparticles.

Savolainen M, Herder J, Khoo C, Lövqvist K, Dahlqvist C, Glad H, Juppo AM.

Int J Pharm. 2003 Aug 27;262(1-2):47-62.

PMID:
12927387

Supplemental Content

Support Center